Logo image of PEN

PENUMBRA INC (PEN) Stock Price, Quote, News and Overview

NYSE:PEN - New York Stock Exchange, Inc. - US70975L1070 - Common Stock - Currency: USD

272.63  +4.09 (+1.52%)

After market: 272.63 0 (0%)

PEN Quote, Performance and Key Statistics

PENUMBRA INC

NYSE:PEN (5/27/2025, 8:04:00 PM)

After market: 272.63 0 (0%)

272.63

+4.09 (+1.52%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High310
52 Week Low148
Market Cap10.56B
Shares38.73M
Float37.38M
Yearly DividendN/A
Dividend YieldN/A
PE82.87
Fwd PE53.43
Earnings (Next)07-28 2025-07-28/amc
IPO09-18 2015-09-18


PEN short term performance overview.The bars show the price performance of PEN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10

PEN long term performance overview.The bars show the price performance of PEN in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80

The current stock price of PEN is 272.63 USD. In the past month the price decreased by -8.3%. In the past year, price increased by 43.89%.

PENUMBRA INC / PEN Daily stock chart

PEN Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.81 231.29B
ISRG INTUITIVE SURGICAL INC 72.01 197.20B
BSX BOSTON SCIENTIFIC CORP 39.32 157.07B
SYK STRYKER CORP 30.63 146.67B
MDT MEDTRONIC PLC 14.76 104.12B
BDX BECTON DICKINSON AND CO 12.39 50.02B
EW EDWARDS LIFESCIENCES CORP 29.32 44.71B
IDXX IDEXX LABORATORIES INC 45.31 41.86B
RMD RESMED INC 27.12 36.10B
DXCM DEXCOM INC 51.72 33.46B
GEHC GE HEALTHCARE TECHNOLOGY 15.44 32.51B
STE STERIS PLC 26.36 24.19B

About PEN

Company Profile

PEN logo image Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. The company is headquartered in Alameda, California and currently employs 4,500 full-time employees. The company went IPO on 2015-09-18. The firm designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. The company is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. The company is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The firm sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Company Info

PENUMBRA INC

One Penumbra Place

Alameda CALIFORNIA 94502 US

CEO: Adam Elsesser

Employees: 4500

PEN Company Website

PEN Investor Relations

Phone: 15109952486

PENUMBRA INC / PEN FAQ

What is the stock price of PENUMBRA INC today?

The current stock price of PEN is 272.63 USD. The price increased by 1.52% in the last trading session.


What is the ticker symbol for PENUMBRA INC stock?

The exchange symbol of PENUMBRA INC is PEN and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is PEN stock listed?

PEN stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for PENUMBRA INC stock?

24 analysts have analysed PEN and the average price target is 325.26 USD. This implies a price increase of 19.3% is expected in the next year compared to the current price of 272.63. Check the PENUMBRA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PENUMBRA INC worth?

PENUMBRA INC (PEN) has a market capitalization of 10.56B USD. This makes PEN a Large Cap stock.


How many employees does PENUMBRA INC have?

PENUMBRA INC (PEN) currently has 4500 employees.


What are the support and resistance levels for PENUMBRA INC (PEN) stock?

PENUMBRA INC (PEN) has a support level at 265.53 and a resistance level at 277.22. Check the full technical report for a detailed analysis of PEN support and resistance levels.


Is PENUMBRA INC (PEN) expected to grow?

The Revenue of PENUMBRA INC (PEN) is expected to grow by 13.8% in the next year. Check the estimates tab for more information on the PEN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PENUMBRA INC (PEN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PENUMBRA INC (PEN) stock pay dividends?

PEN does not pay a dividend.


When does PENUMBRA INC (PEN) report earnings?

PENUMBRA INC (PEN) will report earnings on 2025-07-28, after the market close.


What is the Price/Earnings (PE) ratio of PENUMBRA INC (PEN)?

The PE ratio for PENUMBRA INC (PEN) is 82.87. This is based on the reported non-GAAP earnings per share of 3.29 and the current share price of 272.63 USD. Check the full fundamental report for a full analysis of the valuation metrics for PEN.


What is the Short Interest ratio of PENUMBRA INC (PEN) stock?

The outstanding short interest for PENUMBRA INC (PEN) is 4.13% of its float. Check the ownership tab for more information on the PEN short interest.


PEN Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to PEN. When comparing the yearly performance of all stocks, PEN is one of the better performing stocks in the market, outperforming 87.85% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PEN Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to PEN. While PEN has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PEN Financial Highlights

Over the last trailing twelve months PEN reported a non-GAAP Earnings per Share(EPS) of 3.29. The EPS increased by 44.93% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.41%
ROA 2.65%
ROE 3.48%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%102.44%
Sales Q2Q%16.32%
EPS 1Y (TTM)44.93%
Revenue 1Y (TTM)13.18%

PEN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to PEN. The Buy consensus is the average rating of analysts ratings from 24 analysts.

For the next year, analysts expect an EPS growth of 33.54% and a revenue growth 13.8% for PEN


Ownership
Inst Owners92.16%
Ins Owners3.87%
Short Float %4.13%
Short Ratio3.16
Analysts
Analysts82.5
Price Target325.26 (19.3%)
EPS Next Y33.54%
Revenue Next Year13.8%